Does ESOMEPRAZOLE Cause Hepatic steatosis? 60 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 60 reports of Hepatic steatosis have been filed in association with ESOMEPRAZOLE (Esomeprazole Magnesium). This represents 0.1% of all adverse event reports for ESOMEPRAZOLE.
60
Reports of Hepatic steatosis with ESOMEPRAZOLE
0.1%
of all ESOMEPRAZOLE reports
0
Deaths
42
Hospitalizations
How Dangerous Is Hepatic steatosis From ESOMEPRAZOLE?
Of the 60 reports, 42 (70.0%) required hospitalization, and 4 (6.7%) were considered life-threatening.
Is Hepatic steatosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ESOMEPRAZOLE. However, 60 reports have been filed with the FAERS database.
What Other Side Effects Does ESOMEPRAZOLE Cause?
Chronic kidney disease (35,281)
Acute kidney injury (18,678)
Renal failure (14,633)
End stage renal disease (10,231)
Renal injury (9,440)
Gastrooesophageal reflux disease (4,746)
Drug ineffective (4,420)
Tubulointerstitial nephritis (4,024)
Off label use (3,180)
Pain (2,898)
What Other Drugs Cause Hepatic steatosis?
METHOTREXATE (1,400)
ADALIMUMAB (1,058)
ETANERCEPT (620)
TOCILIZUMAB (476)
TOFACITINIB (405)
LEFLUNOMIDE (359)
HYDROXYCHLOROQUINE (358)
ABATACEPT (345)
METFORMIN (343)
INFLIXIMAB (325)
Which ESOMEPRAZOLE Alternatives Have Lower Hepatic steatosis Risk?
ESOMEPRAZOLE vs ESOMEPRAZOLE\ESOMEPRAZOLE\ESOMEPRAZOLE
ESOMEPRAZOLE vs ESOMEPRAZOLE\NAPROXEN
ESOMEPRAZOLE vs ESTAZOLAM
ESOMEPRAZOLE vs ESTRADIOL
ESOMEPRAZOLE vs ESTRADIOL CYPIONATE